FDA readies new vax safety site

The FDA has posted a new Web site that spells out the safety information that has been gleaned from recently launched vaccines and biologics. The agency is using the site to share what safety information it has gathered on a drug 18 months after its approval or after 10,000 people have used it, whichever comes first. The agency plans to scan a broad base of data on adverse events. Report

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.